HNF4A and prostate carcinoma: In vitro cell proliferation assay showed that contrary to shHNF4α infectants, all the immunoblot-validated HNF4α-infectants of prostate cancer cells proliferated at slower rates than their empty vector-infectants (Fig. 5a, b).